DRMA vs ABBV
Head-to-Head Stock Analysis & Investment Rating
Last Updated: Apr 27, 2026
DRMA
ABBV
Investment Advisor Scores
ABBV
AI Analyst Insights
Detailed Metrics Comparison
| Metric | DRMA | ABBV | Winner |
|---|---|---|---|
|
Valuation
Lower P/E and PEG ratios suggest a stock may be undervalued relative to earnings and growth. Value investors prefer lower multiples. |
|||
| Forward P/E | 0 | 14.1844 | Tie |
| PEG Ratio | 0 | 0.4709 | Tie |
|
Growth
Higher revenue and earnings growth rates indicate a company is expanding faster. Strong growth often justifies premium valuations. |
|||
| Revenue Growth | 0.0% | 10.0% | ABBV |
| Earnings Growth | 0.0% | -88.7% | DRMA |
|
Quality & Profitability
Higher Tradestie Score and profit margins reveal how efficiently a company operates. Strong profitability indicates competitive advantages. |
|||
| Tradestie Score | 45.0/100 | 53.4/100 | ABBV |
| Profit Margin | 0.0% | 6.9% | ABBV |
|
Risk Profile
Lower Beta and Implied Volatility values indicate reduced market risk. Conservative investors favor stocks with less price volatility. |
|||
| Beta | 1.00 | 1.00 | Tie |
|
Sentiment
AI Recommendation reflects overall analyst and proprietary sentiment. Stronger recommendations signal higher conviction. |
|||
| AI Recommendation | HOLD | HOLD | Tie |